Financials in USD. Standardized financial statements.
A compact view of how AlzChem Group AG turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $561.90M | $554.23M | $540.65M | $542.22M | $422.29M | $379.26M | $376.07M | $375.22M | $353.92M | $327.19M |
| Revenue Growth? | +1.4% | +2.5% | -0.3% | +28.4% | +11.3% | +0.8% | +0.2% | +6.0% | +8.2% | 0.0% |
| Cost of Revenue? | $384.38M | $193.51M | $241.72M | $259.50M | $153.96M | $128.68M | $138.79M | $143.05M | $129.94M | $241.40M |
| Gross Profit? | $177.52M | $360.73M | $298.93M | $282.72M | $268.34M | $250.58M | $237.28M | $232.17M | $223.98M | $85.78M |
| Gross Margin? | +31.6% | +65.1% | +55.3% | +52.1% | +63.5% | +66.1% | +63.1% | +61.9% | +63.3% | +26.2% |
| Operating Expenses? | $94.76M | $282.60M | $160.76M | $252.16M | $230.80M | $218.07M | $207.03M | $192.41M | $190.14M | $28,368 |
| Operating Income? | $82.76M | $78.13M | $143.30M | $61.44M | $38.22M | $31.01M | $30.85M | $40.39M | $32.19M | -$28,368.85 |
| EBITDA? | $109.40M | $107.49M | $81.75M | $69.86M | $62.68M | $54.13M | $50.34M | $49.77M | $46.32M | $43.20M |
| Income Before Tax | $87.91M | $75.34M | $48.19M | $41.28M | $36.51M | $27.20M | $25.49M | $31.92M | $29.34M | -$28,752.33 |
| Income Tax Expense | $24.30M | $21.10M | $13.40M | $11.06M | $8.75M | $7.33M | $7.34M | $9.14M | $8.76M | $6.60M |
| Net Income? | $63.44M | $54.08M | $34.62M | $30.05M | $27.59M | $19.69M | $17.98M | $22.64M | $20.39M | -$28,752.33 |
| EPS? | $6.27 | $5.31 | $3.40 | $2.97 | $2.72 | $1.94 | $1.77 | $2.23 | $2.00 | $-0.13 |
| Diluted EPS? | $6.27 | $5.31 | $3.40 | $2.97 | $2.72 | $1.94 | $1.77 | $2.23 | $2.00 | $-0.13 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality